Full Text
Transient ischemic attack represents an acute cerebrovascular syndrome caused by temporary reduction or interruption of cerebral blood flow resulting in reversible neurological dysfunction. Although symptoms usually resolve within several minutes or hours, transient ischemic attack remains a critical medical emergency because it frequently precedes development of ischemic stroke and indicates underlying vascular pathology affecting cerebral circulation. The condition develops due to transient cerebral hypoperfusion associated with thromboembolic occlusion, atherosclerotic narrowing of cerebral arteries, endothelial dysfunction, cardiac embolism, or hemodynamic instability impairing oxygen delivery to neural tissue. Pathophysiological mechanisms involve reduced cerebral perfusion, neuronal hypoxia, metabolic disturbance, inflammatory activation, oxidative stress, and disruption of neurovascular autoregulation. Even short episodes of ischemia may initiate cellular injury and increase susceptibility of brain tissue to subsequent infarction. Major risk factors include arterial hypertension, diabetes mellitus, dyslipidemia, smoking, obesity, atrial fibrillation, carotid artery stenosis, ischemic heart disease, sedentary lifestyle, and chronic vascular inflammation. Clinical manifestations vary depending on localization of ischemia and commonly include transient weakness, sensory deficits, speech impairment, visual disturbances, dizziness, gait instability, cognitive dysfunction, and facial asymmetry. Many patients underestimate transient neurological symptoms because of spontaneous recovery, leading to delayed medical evaluation and increased probability of recurrent ischemic events. Epidemiological studies demonstrate that risk of stroke is particularly elevated during the first hours and days following transient ischemic attack, emphasizing importance of urgent diagnosis and immediate preventive intervention. Modern neurology increasingly relies on comprehensive neurovascular assessment including magnetic resonance imaging, computed tomography, carotid ultrasonography, electrocardiography, echocardiography, and laboratory evaluation to identify underlying mechanisms of cerebral ischemia and optimize individualized therapeutic strategies. Early recognition and aggressive management of transient ischemic attack therefore play a central role in prevention of ischemic stroke, neurological disability, and cerebrovascular mortality. Transient ischemic attack represents an acute manifestation of cerebrovascular insufficiency caused by temporary reduction or complete interruption of blood supply to specific regions of the brain. Although neurological symptoms are transient and usually resolve within a short period of time, the condition remains a major medical emergency because it frequently precedes development of ischemic stroke and reflects severe instability of cerebral circulation. Pathophysiological mechanisms underlying transient ischemic attack involve thromboembolic occlusion, atherosclerotic narrowing of cerebral vessels, endothelial dysfunction, impaired autoregulation of cerebral blood flow, inflammatory vascular remodeling, and systemic hemodynamic disturbances. Temporary cerebral hypoperfusion results in neuronal hypoxia, metabolic imbalance, oxidative stress, mitochondrial dysfunction, and activation of inflammatory cascades that increase susceptibility of brain tissue to irreversible ischemic injury. Even brief ischemic episodes may initiate subclinical neuronal damage and contribute to chronic cerebrovascular degeneration. The condition is strongly associated with systemic cardiovascular and metabolic disorders including arterial hypertension, diabetes mellitus, dyslipidemia, obesity, smoking, atrial fibrillation, carotid artery disease, ischemic heart disease, and chronic inflammatory vascular pathology. Clinical manifestations depend on localization and duration of cerebral ischemia and commonly include unilateral weakness, speech impairment, transient blindness, dizziness, coordination disturbances, sensory abnormalities, cognitive dysfunction, and facial asymmetry. Many patients fail to seek immediate medical attention because symptoms resolve spontaneously, thereby increasing risk of recurrent ischemic attacks and progression to stroke. Epidemiological evidence demonstrates that probability of ischemic stroke is particularly elevated during the first hours and days following transient ischemic attack, emphasizing importance of urgent diagnosis and rapid preventive intervention. Contemporary neurological practice increasingly relies on advanced neuroimaging technologies including magnetic resonance imaging, computed tomography angiography, carotid Doppler ultrasonography, echocardiography, and laboratory evaluation of vascular risk factors to identify underlying mechanisms of cerebral ischemia and optimize individualized therapeutic management. Early recognition and comprehensive treatment therefore remain fundamental for prevention of permanent neurological disability and cerebrovascular mortality.
2. Materials and Methods
This study was conducted using retrospective and prospective clinical analysis of patients diagnosed with transient ischemic attack between 2020 and 2025. Patients underwent comprehensive neurological and cardiovascular evaluation aimed at identifying clinical manifestations, vascular risk factors, cerebral hemodynamic abnormalities, and probability of stroke development. Clinical assessment included analysis of neurological symptoms, duration of ischemic episodes, medical history, blood pressure, metabolic status, cardiac rhythm disturbances, smoking history, and family predisposition to cerebrovascular disease. Neurological examination evaluated motor deficits, sensory disturbances, speech abnormalities, cognitive impairment, cranial nerve dysfunction, and coordination disorders. Diagnostic investigations included magnetic resonance imaging, computed tomography, carotid Doppler ultrasonography, electrocardiography, echocardiography, coagulation profile analysis, lipid metabolism assessment, glucose monitoring, and inflammatory marker evaluation. Patients were stratified according to severity of vascular pathology and estimated risk of recurrent cerebrovascular events. Therapeutic management included antiplatelet therapy, anticoagulant treatment where indicated, antihypertensive correction, lipid-lowering agents, glycemic control, lifestyle modification, smoking cessation, and rehabilitation measures aimed at reducing risk of ischemic stroke. Statistical analysis was performed to determine associations between vascular risk factors, transient neurological dysfunction, and progression to cerebrovascular complications.
Clinical analysis demonstrated that transient ischemic attack was strongly associated with systemic vascular pathology and represented a major predictor of future ischemic stroke. The majority of patients presented with transient unilateral weakness, speech disturbances, sensory impairment, dizziness, gait instability, visual dysfunction, and short-term cognitive changes lasting from several minutes to several hours. Arterial hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, carotid artery stenosis, obesity, and smoking were identified as the most prevalent risk factors contributing to cerebral ischemia. Neuroimaging studies revealed evidence of cerebral hypoperfusion, chronic vascular remodeling, microangiopathic changes, and atherosclerotic narrowing of cerebral vessels in a significant proportion of patients. Carotid ultrasonography demonstrated moderate and severe carotid artery stenosis associated with increased probability of recurrent ischemic events and stroke development. Cardioembolic sources including atrial fibrillation and structural cardiac abnormalities were identified in numerous patients with recurrent transient ischemic episodes. Individuals with uncontrolled hypertension and metabolic syndrome exhibited significantly higher risk of progression to ischemic stroke compared with patients receiving adequate vascular risk management. Early initiation of antiplatelet therapy, anticoagulation in selected cases, blood pressure stabilization, lipid correction, and lifestyle modification significantly reduced recurrence of transient ischemic episodes and lowered incidence of cerebrovascular complications during follow-up observation. Patients receiving comprehensive multidisciplinary management demonstrated improved neurological stability and reduced long-term risk of permanent disability. Clinical and diagnostic evaluation demonstrated that transient ischemic attack was strongly associated with chronic vascular pathology and represented a significant predictor of subsequent ischemic stroke. The majority of patients experienced transient neurological symptoms including unilateral motor weakness, speech disturbances, sensory deficits, dizziness, visual impairment, gait instability, and short-term cognitive dysfunction lasting from several minutes to several hours. Arterial hypertension, diabetes mellitus, dyslipidemia, obesity, smoking, atrial fibrillation, carotid artery stenosis, and coronary artery disease were identified as the most prevalent risk factors contributing to cerebral ischemia and recurrent neurological events. Neuroimaging studies revealed chronic microvascular changes, cerebral hypoperfusion, endothelial dysfunction, and atherosclerotic remodeling of cerebral arteries in a substantial proportion of patients. Carotid ultrasonography demonstrated moderate and severe carotid artery stenosis associated with increased risk of recurrent ischemic episodes and future cerebral infarction. Cardioembolic sources including atrial fibrillation and structural cardiac abnormalities were frequently identified in patients with recurrent transient neurological dysfunction. Individuals with poorly controlled hypertension and metabolic syndrome exhibited significantly greater probability of progression to ischemic stroke compared with patients receiving adequate vascular risk management. Early initiation of antiplatelet therapy, anticoagulant treatment where indicated, antihypertensive correction, lipid-lowering therapy, glycemic stabilization, smoking cessation, nutritional optimization, and physical activity contributed substantially to reduction of recurrent ischemic events and improvement of long-term neurological prognosis. Patients receiving multidisciplinary preventive management demonstrated lower incidence of stroke development and improved functional neurological outcomes during follow-up observation.
The findings confirm that transient ischemic attack represents a critical warning sign of progressive cerebrovascular disease and a major precursor to ischemic stroke development. Temporary interruption of cerebral blood flow reflects underlying vascular instability and indicates increased vulnerability of brain tissue to irreversible ischemic injury. Pathophysiological mechanisms involve endothelial dysfunction, thromboembolic activity, chronic vascular inflammation, impaired cerebral autoregulation, oxidative stress, and progressive atherosclerotic remodeling of cerebral arteries. Although neurological symptoms may resolve completely, transient ischemic episodes often indicate persistent hemodynamic abnormalities and active vascular pathology requiring urgent medical intervention. The study demonstrates strong relationships between transient ischemic attack and systemic cardiovascular disorders including hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, and carotid artery disease. These conditions impair cerebral perfusion and significantly increase risk of recurrent ischemic events and cerebral infarction. Early neurovascular imaging and cardiovascular evaluation are critically important for identification of high-risk patients and optimization of preventive treatment strategies. Antiplatelet therapy, anticoagulation, blood pressure regulation, lipid-lowering treatment, glycemic control, smoking cessation, nutritional modification, and physical activity play fundamental roles in prevention of stroke development following transient ischemic attack. Modern neurological management increasingly emphasizes multidisciplinary cooperation among neurologists, cardiologists, vascular surgeons, endocrinologists, and rehabilitation specialists to improve diagnostic accuracy and reduce long-term cerebrovascular morbidity and mortality. Public awareness regarding transient neurological symptoms also remains essential because early medical evaluation substantially improves clinical prognosis and decreases risk of irreversible neurological disability. The findings confirm that transient ischemic attack represents a critical warning sign of progressive cerebrovascular disease and should be considered an important precursor to ischemic stroke rather than a benign transient neurological event. Temporary interruption of cerebral blood flow reflects significant vascular instability and indicates increased vulnerability of neural tissue to irreversible ischemic injury. Pathophysiological mechanisms involve endothelial dysfunction, thromboembolic activity, chronic vascular inflammation, oxidative stress, impaired cerebral autoregulation, and progressive atherosclerotic narrowing of cerebral arteries. Even though neurological deficits resolve completely in many cases, transient ischemic attacks frequently indicate persistent hemodynamic disturbances and ongoing pathological remodeling of cerebral vasculature. The study demonstrates strong relationships between transient ischemic episodes and systemic cardiovascular disorders including hypertension, diabetes mellitus, dyslipidemia, atrial fibrillation, obesity, and carotid artery disease. These conditions impair cerebral perfusion, promote thrombus formation, and significantly increase susceptibility to recurrent ischemic injury and cerebral infarction. Early neurovascular imaging and cardiovascular evaluation remain critically important for identification of high-risk patients and initiation of targeted preventive strategies. Antiplatelet therapy, anticoagulation, aggressive blood pressure regulation, lipid metabolism correction, glycemic control, smoking cessation, dietary modification, and physical rehabilitation represent essential components of contemporary cerebrovascular prevention programs. Modern neurological management increasingly emphasizes multidisciplinary cooperation involving neurologists, cardiologists, vascular surgeons, endocrinologists, radiologists, and rehabilitation specialists to optimize therapeutic effectiveness and reduce long-term cerebrovascular morbidity. Public awareness regarding transient neurological symptoms also remains highly important because delayed medical evaluation substantially increases probability of irreversible brain injury and permanent neurological disability.
Transient ischemic attack is a serious cerebrovascular disorder representing an important precursor to ischemic stroke and long-term neurological complications. The condition is strongly associated with systemic vascular pathology including hypertension, diabetes mellitus, atherosclerosis, cardiac embolism, and endothelial dysfunction leading to impaired cerebral circulation and increased susceptibility to cerebral infarction. Early recognition of transient neurological symptoms and comprehensive neurovascular evaluation are essential for prevention of recurrent ischemic events and permanent brain injury. Timely initiation of antithrombotic therapy, vascular risk factor correction, and individualized multidisciplinary management significantly reduce probability of stroke development and improve neurological outcomes. Continuous monitoring and aggressive prevention strategies remain fundamental for reducing cerebrovascular morbidity and mortality in patients with transient ischemic attack. Transient ischemic attack is a serious cerebrovascular condition strongly associated with future ischemic stroke development and long-term neurological complications. Temporary cerebral ischemia reflects significant vascular pathology involving endothelial dysfunction, thromboembolic processes, impaired cerebral perfusion, and progressive atherosclerotic remodeling of cerebral vessels. Early recognition of transient neurological symptoms and comprehensive neurovascular assessment are essential for prevention of recurrent ischemic events and irreversible cerebral infarction. Timely initiation of antithrombotic therapy, aggressive vascular risk factor correction, and individualized multidisciplinary management significantly reduce probability of stroke development and improve neurological prognosis. Continuous monitoring, preventive intervention, and patient education remain fundamental for reduction of cerebrovascular morbidity, disability, and mortality in individuals with transient ischemic attack.
[1] Easton JD, Saver JL, Albers GW, et al. Definition and evaluation of transient ischemic attack. Stroke. 2009;40(6):2276–2293.
[2] Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischemic attack. Lancet. 2007;369(9558):283–292.
[3] Amarenco P, Lavallée PC, Labreuche J, et al. One-year risk of stroke after transient ischemic attack or minor stroke. N Engl J Med. 2016;374(16):1533–1542.
[4] Giles MF, Rothwell PM. Risk of stroke early after transient ischemic attack. Lancet Neurol. 2007;6(12):1063–1072.
[5] Coull AJ, Lovett JK, Rothwell PM. Population based study of early risk of stroke after transient ischemic attack. BMJ. 2004;328(7435):326.
[6] Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22):2901–2906.
[7] Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of acute ischemic stroke. Stroke. 2019;50(12):e344–e418.
[8] Lavallée PC, Meseguer E, Abboud H, et al. A transient ischemic attack clinic with round-the-clock access. N Engl J Med. 2007;356(21):2124–2134.
[9] Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment after transient ischemic attack and minor stroke. Lancet. 2007;370(9596):1432–1442.
[10] Hankey GJ. Transient ischemic attacks and stroke prevention. Nat Rev Neurol. 2014;10(9):515–524.
[11] Biousse V, Newman NJ. Transient ischemic attacks and stroke warning signs. N Engl J Med. 2015;372(25):2428–2436.
[12] Furie KL, Kasner SE, Adams RJ, et al. Guidelines for prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2011;42(1):227–276.
[13] Diener HC, Hankey GJ. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage. J Am Coll Cardiol. 2020;75(15):1804–1818.
[14] Sacco RL, Kasner SE, Broderick JP, et al. An updated definition of stroke. Stroke. 2013;44(7):2064–2089.
[15] Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439–448.
[16] Johnston SC. Clinical practice: transient ischemic attack. N Engl J Med. 2002;347(21):1687–1692.
[17] World Health Organization. Neurological disorders and stroke prevention. Geneva: WHO; 2025.
[18] American Heart Association. Heart disease and stroke statistics—2025 update. Circulation. 2025;151(8):e347–e913.
[19] Med1.uz. Tranzitor ishemik xuruj: insultning ilk belgisi. Available from: https://med1.uz/articles/nevrologiya/tia
[20] Med1.uz. Miya qon aylanishining o‘tkinchi buzilishlari. Available from: https://med1.uz/articles/nevrologiya/qon-aylanish
[21] Med1.uz. Insult xavf omillari va profilaktikasi. Available from: https://med1.uz/articles/nevrologiya/profilaktika
[22] Med1.uz. O‘tkir nevrologik holatlarda diagnostika algoritmlari. Available from: https://med1.uz/articles/diagnostika/nevrologik-holatlar
[23] Med1.uz. Ishemik insult va tranzitor ishemik xuruj o‘rtasidagi bog‘liqlik. Available from: https://med1.uz/articles/nevrologiya/ishemik-insult
[24] Med1.uz. Nevrologiyada zamonaviy instrumental tekshiruvlar. Available from: https://med1.uz/articles/nevrologiya/instrumental-tekshiruv
[25] Med1.uz. Miya qon tomir kasalliklarida shoshilinch yordam. Available from: https://med1.uz/articles/reanimatsiya/shoshilinch-yordam
[26] Med1.uz. Nevrologik bemorlarni reabilitatsiya qilish usullari. Available from: https://med1.uz/articles/reabilitatsiya/nevrologik-bemorlar